SLC26A9 promotes the development and stemness of triple-negative breast cancer via activating EGFR/PI3 K/AKT signaling pathway

被引：0
|
作者：
Zhou, Z. [1 ]
Ma, Z. [2 ]
Lu, C. [1 ]
Liu, X. [2 ]
Lv, J. [1 ]
Zhang, C. [1 ]
Wang, H. [1 ]
Mu, R. [1 ]
Cheng, X. [1 ]
Tuo, B. [2 ]
Li, T. [1 ]
机构：
[1] Zunyi Med Univ, Dept Gen Surg, Affiliated Hosp, Zunyi, Guizhou, Peoples R China
[2] Zunyi Med Univ, Digest Dis Hosp, Dept Gastroenterol, Affiliated Hosp, Zunyi, Guizhou, Peoples R China
来源：
BREAST | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P035
引用
收藏
页码：S29 / S30
页数：2
相关论文
共 50 条
  • [1] SLC26A9 promotes the initiation and progression of breast cancer by activating the PI3K/AKT signaling pathway
    Ma, Zhiyuan
    Wang, Hu
    Zhou, Zhengxing
    Lu, Chengli
    Zhang, Minglin
    Mu, Renmin
    Zhang, Chengmin
    Yi, Zhiqiang
    Deng, Zilin
    Zhao, Yingying
    Zhu, Jiaxing
    Wen, Guorong
    Jin, Hai
    An, Jiaxing
    Tuo, Biguang
    Yuan, Peng
    Liu, Xuemei
    Li, Taolang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2025, 1872 (03):
  • [2] Upregulation of SLC26A9 resulted in the development and progression of HER2-positive breast cancer via activating PI3 K/AKT signaling pathway
    Ma, Z.
    Lu, C.
    Zhu, J.
    Cheng, X.
    Tuo, B.
    Liu, X.
    Li, T.
    BREAST, 2021, 56 : S26 - S26
  • [3] SLC26A9 promotes triple-negative breast cancer progression by regulating lipid metabolism
    Zhou, Yingming
    Wang, Hu
    Zhou, Zhengxing
    Liu, Xuemei
    Tuo, Biguang
    Li, Taolang
    CANCER RESEARCH, 2024, 84 (09)
  • [4] Targeting PI3K/AKT pathway in triple-negative breast cancer
    Delaloge, Suzette
    DeForceville, Louise
    LANCET ONCOLOGY, 2017, 18 (10): : 1293 - 1294
  • [5] Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling
    Cheng, Wei
    Liu, Dan
    Guo, Min
    Li, Honglei
    Wang, Qiang
    DRUG DEVELOPMENT RESEARCH, 2022, 83 (05) : 1138 - 1151
  • [6] Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway
    Fan, Shaoxia
    Yan, Shen
    Yang, Yang
    Shang, Jian
    Hao, Min
    ONCOTARGETS AND THERAPY, 2021, 14 : 2463 - 2473
  • [7] Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
    不详
    BIOSCIENCE REPORTS, 2024, 44 (07)
  • [8] Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
    Xu, Yonggang
    Fang, Rong
    Shao, Jie
    Cai, Zihao
    BIOSCIENCE REPORTS, 2021, 41 (04)
  • [9] JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway
    Li, Jianjie
    Zhang, Xiangmei
    Liu, Xueliang
    Ma, Xiangmin
    Wang, Yanfang
    Liu, Yunjiang
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (10) : 1029 - 1040
  • [10] Rujifang inhibits triple-negative breast cancer growth via the PI3K/ AKT pathway
    Jia, Wenyu
    Lin, Xuan
    Chen, Xuezhang
    Li, Hongliang
    Zhang, Xingru
    Zhang, Yuzhuo
    Chen, Yinsong
    Wang, Bin
    Chen, Xikang
    Chen, Ju
    Tian, Huaqin
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 327
12345